Biodesix Q4 Earnings Call Highlights [Yahoo! Finance]
Biodesix, Inc. (BDSX)
Company Research
Source: Yahoo! Finance
24%), with gross margins of 83% in Q4 and 81% for the year; the company posted its first positive adjusted EBITDA quarter at $0.53M and guided 2026 revenue to $106–112M (˜23% growth at midpoint). Lung diagnostics remain the growth engine: Lung diagnostics generated $25.1M in Q4 with 18,000 tests (62,600 tests for FY), driven by higher average revenue per test from improved reimbursement and an expanded commercial push into primary care (primary care volumes +67% YoY in Q4). Balanced capital and pipeline discipline: Biodesix ended the quarter with $19.0M cash (pro forma ~$33.7M including ATM proceeds and an additional $14.7M raised after quarter-end), extended its term loan, grew development services revenue and partnerships, but will defer commercializing pipeline tests for at least 12 months to prioritize profitability and reimbursement timing. Interested in Biodesix, Inc.? Here are five stocks we like better. Biodesix (NASDAQ:BDSX) reported fourth-quarter and full-year 2025
Show less
Read more
Impact Snapshot
Event Time:
BDSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDSX alerts
High impacting Biodesix, Inc. news events
Weekly update
A roundup of the hottest topics
BDSX
News
- Are Medical Stocks Lagging Biodesix (BDSX) This Year? [Yahoo! Finance]Yahoo! Finance
- Biodesix (BDSX) was upgraded by William Blair from "market perform" to "outperform".MarketBeat
- Biodesix outlines $106M–$112M 2026 revenue target as sales expansion drives 41% Q4 growth [Seeking Alpha]Seeking Alpha
- Biodesix (BDSX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights [Yahoo! Finance]Yahoo! Finance
BDSX
Earnings
- 2/26/26 - Beat
BDSX
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/23/26 - Form 4
- BDSX's page on the SEC website